BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22911550)

  • 21. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
    Ensafi AA; Amini M; Rezaei B; Talebi M
    Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.
    Gunnarsson R; Mansouri L; Rosenquist R
    Leuk Lymphoma; 2013 Aug; 54(8):1583-90. PubMed ID: 23167608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
    Vavrova E; Kantorova B; Vonkova B; Kabathova J; Skuhrova-Francova H; Diviskova E; Letocha O; Kotaskova J; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Leuk Res; 2017 Sep; 60():145-150. PubMed ID: 28837890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.
    Taylor KH; Kramer RS; Davis JW; Guo J; Duff DJ; Xu D; Caldwell CW; Shi H
    Cancer Res; 2007 Sep; 67(18):8511-8. PubMed ID: 17875690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
    Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
    Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.
    Tripathi R; Lee-Verges E; Higashi M; Gimenez N; Rosich L; Lopez-Guerra M; Colomer D
    Expert Opin Drug Discov; 2017 Oct; 12(10):1041-1052. PubMed ID: 28776453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualifying high-throughput immune repertoire sequencing.
    Niklas N; Pröll J; Weinberger J; Zopf A; Wiesinger K; Krismer K; Bettelheim P; Gabriel C
    Cell Immunol; 2014; 288(1-2):31-8. PubMed ID: 24607567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia.
    Mansouri L; Gunnarsson R; Sutton LA; Ameur A; Hooper SD; Mayrhofer M; Juliusson G; Isaksson A; Gyllensten U; Rosenquist R
    Am J Hematol; 2012 Jul; 87(7):737-40. PubMed ID: 22674506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
    Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
    Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome.
    Mosquera Orgueira A; Rodríguez Antelo B; Díaz Arias JÁ; Díaz Varela N; Alonso Vence N; González Pérez MS; Bello López JL
    Sci Rep; 2020 Feb; 10(1):2407. PubMed ID: 32051441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL.
    Klintman J; Barmpouti K; Knight SJL; Robbe P; Dreau H; Clifford R; Ridout K; Burns A; Timbs A; Bruce D; Antoniou P; Sosinsky A; Becq J; Bentley D; Hillmen P; Taylor JC; Caulfield M; Schuh AH
    Br J Haematol; 2018 Aug; 182(3):412-417. PubMed ID: 29808933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
    Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
    Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
    Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
    Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of high-risk chronic lymphocytic leukemia.
    Rossi D; Gaidano G
    Expert Rev Hematol; 2012 Dec; 5(6):593-602. PubMed ID: 23216591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia.
    Xu JJ; Yao FR; Jiang M; Zhang YT; Guo F
    Int J Mol Med; 2017 Feb; 39(2):415-422. PubMed ID: 28075457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.